verupharma.com (VERU): Expected earnings per share growth for next year
Outsourcing drug production reduces downtime risks, which impacts the estimated annual EPS growth for the next period as illustrated by this GURU.Markets chart; the current status is -2.90. Veru Inc. revenues are based on the sale of female contraceptives and oncology drugs. Furthermore, operating exclusively within the US guarantees patent security and minimal geopolitical threats.
Analytical breakdowns and data insights for company Veru Pharma (VERU)
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- book capitalization information:
- debt and solvency information:
- earnings and valuation multiples information:
VERU - Net Income|Future Profit Veru Inc.|VERU - Business Payback Period|Projected Price to Earnings Veru|VERU - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Veru|VERU - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Veru|VERU - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months verupharma.com|VERU - Earnings growth in current year|Earnings growth forecast for next year Veru Inc.
- total revenue and sales volume data:
Fundamental company valuation:verupharma.com, VERU
This indicator measures the consensus forecast for earnings per share changes, allowing for an assessment of market expectations regarding business growth rates. For Veru Inc. (VERU), the trend in expected net income growth per share for the coming year reflects the balance between current sales of women's health products and progress in oncology drug development. Sharp deviations on the chart signal risks of asset overvaluation or the potential for long-term capital growth.
Competitor analysis
ONC (BeiGene Ltd) - Earnings growth forecast for next year|Expected net earnings per share growth next year Halozyme Therapeutics HALO|Net earnings per share growth forecast for next year Revolution Medicines, Inc. (RVMD)|Earnings growth forecast for next year Ascentage Pharma Group International (AAPG)|Earnings growth forecast for next year CGON (CG Oncology Inc)|Expected earnings per share trend next year URGN|bicara.com - Earnings growth forecast for next year|Expected earnings per share trend next year PSNL (personalis.com)|Erasca Inc (ERAS) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Delcath Systems|YMAB (YmAbs) - Earnings growth forecast for next year|AURA: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Candel Therapeutics, Inc. (CADL)|Earnings growth forecast for next year Accuray (ARAY)|Net earnings per share growth forecast for next year SELLAS Life Sciences Group Inc. SLS|Actuate Therapeutics, Inc (ACTU) - Expected net earnings per share growth next year|CTOR - Net earnings per share growth forecast for next year|HURA: Net earnings per share growth forecast for next year|TARA (Protara) - Expected earnings per share growth for next year|Fate Therapeutics, Inc. - Expected earnings per share trend next year|WHWK (aadibio.com) - Earnings growth forecast for next year|TCRX: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Champions Oncology (CSBR)|XBiotech - Projected earnings per share growth rate for next year|Net earnings per share growth forecast for next year CEL-SCI CVM|Consensus forecast of earnings per share growth for next year OS Therapies (OSTX)|Radiopharm Theranostics Limited - Earnings growth forecast for next year|Expected net earnings per share growth next year Artiva Biotherapeutics|ANL (adlainortye.com) - Expected earnings per share growth for next year|Net earnings per share change forecast for next year TPST (Tempest Tx)|XLO (Xilio Therapeutics) - Earnings growth forecast for next year|Expected net earnings per share growth next year renovarobio.com RENB|Net earnings per share growth forecast for next year muraloncology.com (MURA)|Projected earnings per share increase next year KAPA|Earnings growth forecast for next year OKUR (onkuretherapeutics.com)|Projected earnings per share increase next year GDTC (CytoMed)|Curis - Earnings growth forecast for next year|APLM: Net earnings per share growth forecast for next year|Tharimmune (THAR) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Advanced Biomed Inc.|GNPX (Genprex Inc) - Earnings growth forecast for next year|Calidi Biotherapeutics (CLDI) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year SBFM|Net earnings per share growth forecast for next year XBIO (Xenetic Biosciences, Inc.)|Earnings growth forecast for next year SLRX (salariuspharma.com)|PPBT - Expected earnings per share growth for next year|AONC - Net earnings per share growth forecast for next year|Expected earnings per share trend next year BGNE (BeOne Medicines)|CKPT: Earnings growth forecast for next year|Elevation Oncology Inc. (ELEV) - Earnings growth forecast for next year|ICAD (iCAD) - Earnings growth forecast for next year|Earnings growth forecast for next year ikenaoncology.com|Earnings growth forecast for next year NTBL|Earnings growth forecast for next year Viracta Therapeutics Inc. (VIRX)|Net earnings per share growth forecast for next year MorphoSys Inc MOR|Expected earnings per share trend next year NAYA|AAPGV: Expected earnings per share growth for next year
